Chan Paul S, Berg Robert A, Nadkarni Vinay M
Saint Luke's Mid America Heart Institute and University of Missouri, Kansas City (P.S.C.).
The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia (R.A.B., V.M.N.).
Circ Cardiovasc Qual Outcomes. 2020 May;13(5):e006779. doi: 10.1161/CIRCOUTCOMES.120.006779. Epub 2020 Apr 7.
The surging COVID-19 pandemic has raised ethical and moral dilemmas that Western nations with first-rate medical care facilities rarely confront—how to best allocate standard life-saving medical resources when escalating demand outstrips supply. Sadly, these quandaries are familiar challenges in resource-poor countries. What makes this pandemic notable is that the scope and number of reported cases have been primarily in First World nations, raising questions in some settings about the use of emergency treatments like resuscitation care for in-hospital cardiac arrest (IHCA). This perspective reviews the debate around these ethical and moral dilemmas more broadly but focuses specifically on IHCA and the response of the medical community.
汹涌而来的新冠疫情引发了伦理和道德困境，这是拥有一流医疗设施的西方国家很少面临的——当不断增长的需求超过供应时，如何最好地分配标准的救命医疗资源。可悲的是，这些难题在资源匮乏的国家是常见的挑战。此次疫情的显著之处在于，报告病例的范围和数量主要集中在第一世界国家，这在某些情况下引发了关于对院内心脏骤停（IHCA）使用复苏护理等紧急治疗的问题。这篇综述更广泛地审视了围绕这些伦理和道德困境的辩论，但特别关注了院内心脏骤停以及医学界的应对措施。
